{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:26:26Z","timestamp":1785198386544,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.vaccine.2020.10.009","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T04:26:11Z","timestamp":1602822371000},"page":"7629-7637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bacillus Calmette\u2013Gu\u00e9rin (BCG) vaccine generates immunoregulatory cells in the cervical lymph nodes in guinea pigs injected intra dermally"],"prefix":"10.1016","volume":"38","author":[{"given":"Souzan","family":"Vergkizi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1690-1885","authenticated-orcid":false,"given":"Ioannis","family":"Nikolakakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.10.009_b0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41590-019-0583-y","article-title":"Training the trainable cells of the immune system and beyond","volume":"21","author":"Kar","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2020.10.009_b0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0167-5699(85)90025-8","article-title":"Antigen processing and presentation to T cells","volume":"6","author":"Grey","year":"1985","journal-title":"Immunol Today"},{"key":"10.1016\/j.vaccine.2020.10.009_b0015","first-page":"439","article-title":"Monocyte-mediated regulation of cellular immunity in humans: loss of suppressor activity with ageing","volume":"45","author":"Becker","year":"1981","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2020.10.009_b0020","first-page":"439","article-title":"A suppressor B lymphocyte inhibiting IL-2 consumption in spleen cell cultures from Mycobacterium bovis BCG-infected mice","volume":"62","author":"Turcotte","year":"1987","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2020.10.009_b0025","doi-asserted-by":"crossref","unstructured":"Boer MC, van Meijgaarden KE, Joosten SA, Ottenhoff THM. CD8+ regulatory T cells, and not CD4+ T cells, dominate suppressive phenotype and function after in vitro live Mycobacterium bovis-BCG activation of human cells. PLoS One. 2014;9:e94192-e.","DOI":"10.1371\/journal.pone.0094192"},{"key":"10.1016\/j.vaccine.2020.10.009_b0030","first-page":"2573","article-title":"Suppressor adherent cells in human","volume":"121","author":"Ellner","year":"1978","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2020.10.009_b0035","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1172\/JCI108113","article-title":"Hodgkin's disease. An immunodepleting and immunosuppressive disorder","volume":"56","author":"Twomey","year":"1975","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2020.10.009_b0040","doi-asserted-by":"crossref","unstructured":"Shevach EM. The resurrection of T cell-mediated suppression. 2011;186:3805\u20137","DOI":"10.4049\/jimmunol.1100364"},{"key":"10.1016\/j.vaccine.2020.10.009_b0045","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1084\/jem.138.5.1194","article-title":"Requirement for histocompatible macrophages and lymphocytes","volume":"138","author":"Rosenthal","year":"1973","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2020.10.009_b0050","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4049\/jimmunol.126.2.794","article-title":"Antigen-presenting function of alveolar macrophages: uptake and presentation of Listeria monocytogenes","volume":"126","author":"Weinberg","year":"1981","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"key":"10.1016\/j.vaccine.2020.10.009_b0055","first-page":"429","article-title":"Alveolar macrophages. II. Inhibition of lymphocyte proliferation by purified macrophages from rat lung","volume":"37","author":"Holt","year":"1979","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2020.10.009_b0060","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/ATVBAHA.117.308611","article-title":"ATVB distinguished scientist award: how costimulatory and coinhibitory pathways shape atherosclerosis","volume":"37","author":"Ley","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.vaccine.2020.10.009_b0065","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2020.10.009_b0070","doi-asserted-by":"crossref","unstructured":"Kono H, Rock KL. How dying cells alert the immune system to danger 2008;8:279\u201389.","DOI":"10.1038\/nri2215"},{"key":"10.1016\/j.vaccine.2020.10.009_b0075","first-page":"105","article-title":"Aberrant immunoregulatory control of B lymphocyte function in lepromatous leprosy","volume":"49","author":"Bullock","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2020.10.009_b0080","doi-asserted-by":"crossref","unstructured":"Tomioka H, Tatano Y, Maw WW, Sano C, Kanehiro Y, Shimizu T. Characteristics of suppressor macrophages induced by mycobacterial and protozoal infections in relation to alternatively activated M2 macrophages. 2012;2012.","DOI":"10.1155\/2012\/635451"},{"key":"10.1016\/j.vaccine.2020.10.009_b0085","doi-asserted-by":"crossref","unstructured":"Walker C, Kristensen F, Bettens F, DeWeck A. Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production. 1983;130:1770\u20133.","DOI":"10.4049\/jimmunol.130.4.1770"},{"key":"10.1016\/j.vaccine.2020.10.009_b0090","doi-asserted-by":"crossref","unstructured":"Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. 2016;44:450\u201362.","DOI":"10.1016\/j.immuni.2016.02.015"},{"issue":"5","key":"10.1016\/j.vaccine.2020.10.009_b0095","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cytogfr.2010.11.001","article-title":"IL-10 family of cytokines","volume":"21","author":"Sabat","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.vaccine.2020.10.009_b0100","doi-asserted-by":"crossref","unstructured":"Katz S, Parker D, Turk J. B-cell suppression of delayed hypersensitivity reactions. 1974;251:550\u20131.","DOI":"10.1038\/251550a0"},{"key":"10.1016\/j.vaccine.2020.10.009_b0105","doi-asserted-by":"crossref","unstructured":"Sy M-S, Miller SD, Claman HN. Immune suppression with supraoptimal doses of antigen in contact sensitivity: I. Demonstration of suppressor cells and their sensitivity to cyclophosphamide. 1977;119:240\u20134.","DOI":"10.4049\/jimmunol.119.1.240"},{"key":"10.1016\/j.vaccine.2020.10.009_b0110","doi-asserted-by":"crossref","unstructured":"Morikawa Y, Kuribayashi K, Saito K. B-cell-mediated regulation of delayed-type hypersensitivity. 1990;131:338\u201351.","DOI":"10.1016\/0008-8749(90)90259-T"},{"key":"10.1016\/j.vaccine.2020.10.009_b0115","doi-asserted-by":"crossref","unstructured":"James S, Yenokida G, Graeff A, Strober W. Activation of suppressor T cells by autologous lymphoblastoid cells: a mechanism for feedback regulation of immunoglobulin synthesis. 1982;128:1149\u201354.","DOI":"10.4049\/jimmunol.128.3.1149"},{"key":"10.1016\/j.vaccine.2020.10.009_b0120","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1093\/brain\/awy239","article-title":"Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis","volume":"141","author":"Baker","year":"2018","journal-title":"Brain : A J Neurol"},{"key":"10.1016\/j.vaccine.2020.10.009_b0125","doi-asserted-by":"crossref","unstructured":"Narayanan R, Badenoch\u2010Jones P, Curtis J, Turk J. Comparison of mycobacterial granulomas guinea\u2010pig lymph nodes. 1982;138:219\u201333.","DOI":"10.1002\/path.1711380304"},{"key":"10.1016\/j.vaccine.2020.10.009_b0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/erv.09.161","article-title":"BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control","volume":"9","author":"Merle","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.10.009_b0135","doi-asserted-by":"crossref","unstructured":"Berg MK, Yu Q, Salvador CE, Melani I, Kitayama S. Mandated Bacillus Calmette-Gu\u00e9rin (BCG) vaccination predicts flattened curves for the spread of COVID-19. 2020:2020.04.05.20054163.","DOI":"10.1101\/2020.04.05.20054163"},{"key":"10.1016\/j.vaccine.2020.10.009_b0140","doi-asserted-by":"crossref","unstructured":"Covi\u00e1n C, Retamal-D\u00edaz A, Bueno SM, Kalergis AM. Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2? 2020;11.","DOI":"10.3389\/fimmu.2020.00970"},{"key":"10.1016\/j.vaccine.2020.10.009_b0145","unstructured":"Hegarty PK, Ashish K, Zafirakis H, DiNardo A. <Hegarty et al. 2020 BCGvCovid-19_20200326.pdf>. 2020."},{"key":"10.1016\/j.vaccine.2020.10.009_b0150","doi-asserted-by":"crossref","unstructured":"Miller A, Reandelar MJ, Fasciglione K, Roumenova V, Li Y, Otazu GH. Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study. 2020.","DOI":"10.1101\/2020.03.24.20042937"},{"key":"10.1016\/j.vaccine.2020.10.009_b0155","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1016\/j.vaccine.2020.06.083","article-title":"Bacillus Calmette-Gu\u00e9rin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality","volume":"38","author":"Osama El-Gendy","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.10.009_b0160","doi-asserted-by":"crossref","unstructured":"Covi\u00e1n C, Fern\u00e1ndez-Fierro A, Retamal-D\u00edaz A, D\u00edaz FE, Vasquez AE, Lay MK, et al. BCG-induced cross-protection and development of trained immunity: implication for vaccine design. 2019;10.","DOI":"10.3389\/fimmu.2019.02806"},{"key":"10.1016\/j.vaccine.2020.10.009_b0165","doi-asserted-by":"crossref","unstructured":"Dhochak N, Singhal T, Kabra S, Lodha R. Pathophysiology of COVID-19: Why Children Fare Better than Adults? 2020:1.","DOI":"10.1007\/s12098-020-03322-y"},{"key":"10.1016\/j.vaccine.2020.10.009_b0170","doi-asserted-by":"crossref","first-page":"100073","DOI":"10.1016\/j.xcrm.2020.100073","article-title":"Safety and COVID-19 symptoms in individuals recently vaccinated with BCG: a retrospective cohort study","volume":"1","author":"Moorlag Simone","year":"2020","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.vaccine.2020.10.009_b0175","article-title":"Significantly Improved COVID-19 Outcomes in Countries with Higher BCG Vaccination Coverage","volume":"8(3),378","author":"Klinger","year":"2020","journal-title":"2020 A Multivariable Analysis Vaccines"},{"key":"10.1016\/j.vaccine.2020.10.009_b0180","doi-asserted-by":"crossref","unstructured":"Narayanan RB, Badenoch -Jones P, Turk JL. Experimental mycobacterial granulomas in guinea pig lymph nodes: Ultrastructural observations. 1981;134:253\u201365.","DOI":"10.1002\/path.1711340402"},{"key":"10.1016\/j.vaccine.2020.10.009_b0185","doi-asserted-by":"crossref","unstructured":"Gupta S, Curtis J, Turk JL. Accessory cell function of cells of the mononuclear phagocyte system isolated from mycobacterial granulomas. 1985;91:425\u201333.","DOI":"10.1016\/0008-8749(85)90240-0"},{"key":"10.1016\/j.vaccine.2020.10.009_b0190","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1159\/000234708","article-title":"Accessory cell function of dendritic cells from lymph nodes containing <i>mycobacterium leprae<\/i> induced granulomas","volume":"87","author":"Verghese","year":"1988","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.vaccine.2020.10.009_b0195","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0076-6879(84)08095-2","article-title":"Separation of lymphoid cells on nylon wool columns","volume":"108","author":"Litvin","year":"1984","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.vaccine.2020.10.009_b0200","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000234596","article-title":"Phenotypic analysis of guinea pig langerhans cells with antibodies directed against leucocyte surface antigens","volume":"86","author":"Baker","year":"1988","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.vaccine.2020.10.009_b0205","doi-asserted-by":"crossref","unstructured":"Mathew RC, Gupta SK, Katayama I, Curtis J, Turk JL. Macrophage specific antigen is expressed by resting microglia in the CNS but not by Langerhans cells in the skin. 1983;141:435\u201340.","DOI":"10.1002\/path.1711410402"},{"key":"10.1016\/j.vaccine.2020.10.009_b0210","doi-asserted-by":"crossref","unstructured":"Turk J, Narayanan R. The origin, morphology, and function of epithelioid cells. 1982;161:274\u201382.","DOI":"10.1016\/S0171-2985(82)80083-1"},{"key":"10.1016\/j.vaccine.2020.10.009_b0215","doi-asserted-by":"crossref","unstructured":"Boer MC, Joosten SA, Ottenhoff THM. Regulatory T-cells at the interface between human host and pathogens in infectious diseases and vaccination. 2015;6.","DOI":"10.3389\/fimmu.2015.00217"},{"key":"10.1016\/j.vaccine.2020.10.009_b0220","doi-asserted-by":"crossref","unstructured":"Murray HW, Carriero SM, Donelly DM. Presence of a macrophage-mediated suppressor cell mechanism during cell-mediated immune response in experimental visceral leishmaniasis. 1986;54:487\u201393.","DOI":"10.1128\/iai.54.2.487-493.1986"},{"key":"10.1016\/j.vaccine.2020.10.009_b0225","doi-asserted-by":"crossref","unstructured":"Vincendeau P, Bouteille B. Immunology and immunopathology of African trypanosomiasis. 2006;78:645\u201365.","DOI":"10.1590\/S0001-37652006000400004"},{"key":"10.1016\/j.vaccine.2020.10.009_b0230","doi-asserted-by":"crossref","unstructured":"Ptak W, Gershon RK. Immunosuppression effected by macrophage surfaces. 1975;115:1346\u201350.","DOI":"10.4049\/jimmunol.115.5.1346"},{"key":"10.1016\/j.vaccine.2020.10.009_b0235","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0090-1229(80)90024-0","article-title":"Regulation of the immune response by prostaglandins","volume":"15","author":"Goodwin","year":"1980","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2020.10.009_b0240","doi-asserted-by":"crossref","unstructured":"Bullock WE, Carlson EM, Gershon RK. The evolution of immunosuppressive cell populations in experimental mycobacterial infection. 1978;120:1709\u201316.","DOI":"10.4049\/jimmunol.120.5.1709"},{"key":"10.1016\/j.vaccine.2020.10.009_b0245","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1128\/iai.34.2.315-322.1981","article-title":"Evidence for two distinct populations of suppressor cells in the spleens of Mycobacterium bovis BCG-Sensitized mice","volume":"34","author":"Turcotte","year":"1981","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.10.009_b0250","doi-asserted-by":"crossref","unstructured":"Turcotte R, Lemieux S. Mechanisms of action of Mycobacterium bovis BCG-induced suppressor cells in mitogen-induced blastogenesis. 1982;36:263\u201370.","DOI":"10.1128\/iai.36.1.263-270.1982"},{"key":"10.1016\/j.vaccine.2020.10.009_b0255","unstructured":"Ohkawa S, Martin L, Fukunishi Y, Gormus B. Regulatory role of FcR+ and FcR-monocyte subsets in mycobacterium leprae-induced lymphoproliferative response in vitro. 1987;67:43."},{"key":"10.1016\/j.vaccine.2020.10.009_b0260","first-page":"522","article-title":"Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy","volume":"58","author":"Nath","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2020.10.009_b0265","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1172\/JCI23411","article-title":"An integrated view of suppressor T cell subsets in immunoregulation","volume":"114","author":"Jiang","year":"2004","journal-title":"J Clin Investig"},{"key":"10.1016\/j.vaccine.2020.10.009_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2020.10.009_b0275","doi-asserted-by":"crossref","unstructured":"Angelidou A, Diray-Arce J, Conti MG, Smolen KK, van Haren SD, Dowling DJ, et al. BCG as a case study for precision vaccine development: lessons from vaccine heterogeneity, trained immunity, and immune ontogeny. 2020;11.","DOI":"10.3389\/fmicb.2020.00332"},{"issue":"8","key":"10.1016\/j.vaccine.2020.10.009_b0280","first-page":"485","article-title":"Pathology of guinea pigs experimentally infected with a novel reovirus and coronavirus isolated from SARS patients","volume":"24","author":"Liang","year":"2005","journal-title":"Cell Biol"},{"key":"10.1016\/j.vaccine.2020.10.009_b0285","doi-asserted-by":"crossref","unstructured":"Xiaofeng Zhai, Jiumeng Sun, Ziqing Yan, Jie Zhang, Jin Zhao, Zongzheng Zhao, et al. Comparison of SARS-CoV-2 spike protein binding to human, pet, farm animals, and putative intermediate hosts ACE2 and ACE2 receptors. BioRxiv preprint doi: https:\/\/doi.org\/10.1101\/2020.05.08.084061.","DOI":"10.1101\/2020.05.08.084061"},{"key":"10.1016\/j.vaccine.2020.10.009_b0290","doi-asserted-by":"crossref","unstructured":"Wang H, Zhang Y, Huang B, Deng W, Quan Y, Wang W, et al. Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARSCoV-2. Cell 182, 713\u2013721.","DOI":"10.1016\/j.cell.2020.06.008"},{"key":"10.1016\/j.vaccine.2020.10.009_b0295","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16505-0","article-title":"Immunogenicity of a DNA vaccine candidate for COVID-19","volume":"11","author":"Smith","year":"2020","journal-title":"Nat Commun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20312846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20312846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:49:20Z","timestamp":1759402160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20312846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":59,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0264410X20312846"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.10.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacillus Calmette\u2013Gu\u00e9rin (BCG) vaccine generates immunoregulatory cells in the cervical lymph nodes in guinea pigs injected intra dermally","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}